Influence of body mass index on recurrence and quality of life in atrial fibrillation patients after catheter ablation: a meta-analysis and systematic review
- PMID: 23494488
- PMCID: PMC6649556
- DOI: 10.1002/clc.22108
Influence of body mass index on recurrence and quality of life in atrial fibrillation patients after catheter ablation: a meta-analysis and systematic review
Abstract
Background: Accumulating evidence has demonstrated that overweight and obesity, expressed as high body mass index (BMI), are associated with the development of atrial fibrillation (AF) and quality of life (QoL) in AF patients. However, the role of high BMI as a risk factor for prognosis and QoL in AF patients undergoing ablation remains controversial.
Hypothesis: We hypothesized that elevated BMI was correlated with AF recurrence and QoL after an ablative procedure.
Methods: We performed a comprehensive search of PubMed, EMBASE, and the Cochrane Library. Studies were included if they investigated the association of BMI with AF recurrence and QoL after ablation.
Results: Of the 151 articles identified, 12 studies that enrolled 3286 individuals met the inclusion criteria. Overall, compared with normal-BMI patients, AF recurrence occured more frequently in high-BMI patients after ablation (odds ratio: 1.32, 95% confidence interval: 1.17-1.5, P < 0.001). However, the pooled esimate of odds ratio adjusted for multiple confounders did not reach significance. The summary weighted mean difference of BMI between patients with and without recurrence was 0.43 (95% confidence interval: 0.05-0.81, P = 0.027). In addition, QoL scores were significantly lower in high-BMI than in normal-BMI patients before the ablative procedure, whereas the gap of QoL between normal-BMI and high-BMI groups was decreased at follow-up.
Conclusions: Results of this meta-analysis suggest 2 points, namely that the tight association between overweight/obesity and AF recurrence after ablation may be partly due to other concomitant conditions, and that impaired QoL in high-BMI groups is significantly improved after ablation.
© 2013 Wiley Periodicals, Inc.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6649556/bin/CLC-36-269-g004.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6649556/bin/CLC-36-269-g003.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6649556/bin/CLC-36-269-g002.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6649556/bin/CLC-36-269-g001.gif)
Similar articles
-
Obesity effect on newly diagnosed and recurrent post-ablation atrial fibrillation: a systematic review and meta-analysis.J Endocrinol Invest. 2024 May;47(5):1051-1066. doi: 10.1007/s40618-023-02225-x. Epub 2023 Nov 14. J Endocrinol Invest. 2024. PMID: 37962809 Review.
-
Impact of obesity on catheter ablation of atrial fibrillation: Patient characteristics, procedural complications, outcomes, and quality of life.J Cardiovasc Electrophysiol. 2023 Aug;34(8):1648-1657. doi: 10.1111/jce.15987. Epub 2023 Jul 26. J Cardiovasc Electrophysiol. 2023. PMID: 37493505
-
Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients.J Cardiovasc Electrophysiol. 2018 Feb;29(2):239-245. doi: 10.1111/jce.13388. Epub 2017 Dec 14. J Cardiovasc Electrophysiol. 2018. PMID: 29131442
-
Administration of antiarrhythmic drugs to maintain sinus rhythm after catheter ablation for atrial fibrillation: a meta-analysis.Cardiovasc Ther. 2015 Aug;33(4):242-6. doi: 10.1111/1755-5922.12133. Cardiovasc Ther. 2015. PMID: 26031448 Review.
-
Influence of body mass index on quality of life in atrial fibrillation patients undergoing catheter ablation.Heart Rhythm. 2011 Dec;8(12):1847-52. doi: 10.1016/j.hrthm.2011.07.005. Epub 2011 Jul 6. Heart Rhythm. 2011. PMID: 21740879
Cited by
-
Cardiac rehabilitation for patients with obesity: lessons learned from the OPTICARE XL trial.Neth Heart J. 2024 Jan;32(1):14-22. doi: 10.1007/s12471-023-01832-w. Epub 2023 Nov 20. Neth Heart J. 2024. PMID: 37982980 Free PMC article. Review.
-
Role of epicardial adipose tissue in human atrial fibrillation.J Arrhythm. 2023 Feb 19;39(2):93-110. doi: 10.1002/joa3.12825. eCollection 2023 Apr. J Arrhythm. 2023. PMID: 37021018 Free PMC article. Review.
-
Effect of Prolonged and Substantial Weight Loss on Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis.Nutrients. 2023 Feb 14;15(4):940. doi: 10.3390/nu15040940. Nutrients. 2023. PMID: 36839298 Free PMC article. Review.
-
Body mass index and atrial fibrillation recurrence post ablation: A systematic review and dose-response meta-analysis.Front Cardiovasc Med. 2023 Feb 2;9:999845. doi: 10.3389/fcvm.2022.999845. eCollection 2022. Front Cardiovasc Med. 2023. PMID: 36818915 Free PMC article.
-
Short- and long-term risk of atrial fibrillation recurrence after first time ablation according to body mass index: a nationwide Danish cohort study.Europace. 2023 Feb 16;25(2):425-432. doi: 10.1093/europace/euac225. Europace. 2023. PMID: 36480430 Free PMC article.
References
-
- Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol. 2006;26:968–976. - PubMed
-
- Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity‐related health risk factors, 2001. JAMA. 2003;289:76–79. - PubMed
-
- Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305–313. - PubMed
-
- Wang TJ, Parise H, Levy D, et al. Obesity and the risk of new‐onset atrial fibrillation. JAMA. 2004;292:2471–2477. - PubMed
-
- Wanahita N, Messerli FH, Bangalore S, et al. Atrial fibrillation and obesity—results of a meta‐analysis. Am Heart J. 2008;155:310–315. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous